December 8, 2014

Gut hormones in the treatment of short-bowel syndrome and intestinal failure

PJPalle Bekker JeppesenUniversity of Copenhagen

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Gut hormones promote intestinal adaptation and absorption, decreasing fecal losses, thereby decreasing or even eliminating the need for parenteral support. This will aid the intestinal rehabilitation in these severely disabled short-bowel syndrome patients.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Palle Bekker Jeppesen (Mon,) studied this question.

synapsesocial.com/papers/69da28b200ab073a27838099 https://doi.org/https://doi.org/10.1097/med.0000000000000120

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Glucagon-like peptide-2 stimulates mucosal microcirculation measured by laser Doppler flowmetry in end-jejunostomy short bowel syndrome patients2012 · 37 citations
2Some new insights in intestinal failure-associated liver disease2009 · 159 citations
3Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients2005 · 467 citations
4Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function2009 · 100 citations
5Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon2001 · 532 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo